Determinants of mitotic catastrophe on abrogation of the G2 DNA damage checkpoint by UCN-01

Molecular Cancer Therapeutics

Volumn 10, Issue 5, 2011, Pages 784-794

  On, Kin Fan ^a,b   Chen, Yue ^a   Ma, Hoi Tang ^a   Chow, Jeremy P H ^a   Poon, Randy Y C ^a  

^a HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

7 HYDROXYSTAUROSPORINE; BINDING PROTEIN; PROTEIN MAD2; PROTEIN P31 COMET; UNCLASSIFIED DRUG;

ARTICLE; CELL CYCLE G2 PHASE; CELL FATE; CYTOKINESIS; DNA DAMAGE; IONIZING RADIATION; MITOSIS; MITOSIS SPINDLE; PRIORITY JOURNAL; RADIATION DOSE;

ANIMALS; CELL CYCLE PROTEINS; CELL SURVIVAL; CYTOKINESIS; DNA DAMAGE; G2 PHASE; GAMMA RAYS; HCT116 CELLS; HELA CELLS; HUMANS; MICE; MITOSIS; MITOTIC SPINDLE APPARATUS; NIH 3T3 CELLS; PROTEIN KINASE INHIBITORS; STAUROSPORINE;

EID: 79955998513     PISSN: 15357163     EISSN: 15388514     Source Type: Journal    
DOI: 10.1158/1535-7163.MCT-10-0809     Document Type: Article

References (39)

1. Lindqvist A, Rodriguez-Bravo V, Medema RH. The decision to enter mitosis: feedback and redundancy in the mitotic entry network. J Cell Biol 2009;185:193-202.
2. Peters JM. The anaphase promoting complex/cyclosome: a machine designed to destroy. Nat Rev Mol Cell Biol 2006;7:644-56.
3. Musacchio A, Salmon ED. The spindle-assembly checkpoint in space and time. Nat Rev Mol Cell Biol 2007;8:379-93.
4. Kastan MB, Bartek J. Cell-cycle checkpoints and cancer. Nature 2004;432:316-23. (Pubitemid 39551659)
5. Chan TA, Hermeking H, Lengauer C, Kinzler KW, Vogelstein B. 14-3-3Sigma is required to prevent mitotic catastrophe after DNA damage. Nature 1999;401:616-20.
6. Niida H, Tsuge S, Katsuno Y, Konishi A, Takeda N, Nakanishi M. Depletion of Chk1 leads to premature activation of CDC2-cyclin B and mitotic catastrophe. J Biol Chem 2005;280:39246-52. (Pubitemid 41713877)
7. Castedo M, Perfettini JL, Roumier T, Andreau K, Medema R, Kroemer G. Cell death by mitotic catastrophe: a molecular definition. Oncogene 2004;23:2825-37. (Pubitemid 38638845)
8. Vogel C, Hager C, Bastians H. Mechanisms of mitotic cell death induced by chemotherapy-mediated G2 checkpoint abrogation. Cancer Res 2007;67:339-45. (Pubitemid 46142793)
9. Russell P, Nurse P. The mitotic inducer nim1+ functions in a regulatory network of protein kinase homologs controlling the initiation of mitosis. Cell 1987;49:569-76.
10. Russell P, Nurse P. CDC25+ functions as an inducer in the mitotic control of fission yeast. Cell 1986;45:145-53. (Pubitemid 16046635)
11. Chow JPH, Poon RYC. Mitotic catastrophe. In:Enders G, editor. Cell Cycle Deregulation in Cancer. New York: Springer; 2010. p. 79-96.
12. Tenzer A, Pruschy M. Potentiation of DNA-damage-induced cytotoxicity by G2 checkpoint abrogators. Curr Med Chem Anticancer Agents 2003;3:35-46. (Pubitemid 36131633)
13. Wang Q, Fan S, Eastman A, Worland PJ, Sausville EA, O'Connor PM. UCN-01: a potent abrogator of G2 checkpoint function in cancer cells with disrupted p53. J Natl Cancer Inst 1996;88:956-65. (Pubitemid 26239383)
14. Graves PR, Yu L, Schwarz JK, Gales J, Sausville EA, O'Connor PM, et al. The Chk1 protein kinase and the Cdc25C regulatory pathways are targets of the anticancer agent UCN-01. J Biol Chem 2000;275:5600-5. (Pubitemid 30115197)
15. Tse AN, Schwartz GK. Potentiation of cytotoxicity of topoisomerase i poison by concurrent and sequential treatment with the checkpoint inhibitor UCN-01 involves disparate mechanisms resulting in either p53-independent clonogenic suppression or p53-dependent mitotic catastrophe. Cancer Res 2004;64:6635-44. (Pubitemid 39297924)
16. Blagden S, de Bono J. Drugging cell cycle kinases in cancer therapy. Curr Drug Targets 2005;6:325-35. (Pubitemid 40667798)
17. Kortmansky J, Shah MA, Kaubisch A, Weyerbacher A, Yi S, Tong W, et al. Phase I trial of the cyclin-dependent kinase inhibitor and protein kinase C inhibitor 7-hydroxystaurosporine in combination with Fluorouracil in patients with advanced solid tumors. J Clin Oncol 2005;23:1875-84. (Pubitemid 46211365)
18. Yam CH, Ng RW, Siu WY, Lau AW, Poon RYC. Regulation of cyclin A-Cdk2 by SCF component Skp1 and F-box protein Skp2. Mol Cell Biol 1999;19:635-45. (Pubitemid 29018465)
19. Ma HT, Tsang YH, Marxer M, Poon RYC. Cyclin A2-cyclin-dependent kinase 2 cooperates with the PLK1-SCFbeta-TrCP1-EMI1-anaphase-promoting complex/cyclosome axis to promote genome reduplication in the absence of mitosis. Mol Cell Biol 2009;29:6500-14.
20. Ma HT, On KF, Tsang YH, Poon RYC. An inducible system for expression and validation of the specificity of short hairpin RNA in mammalian cells. Nucleic Acids Res 2007;35:e22.
21. Yam CH, Siu WY, Lau A, Poon RYC. Degradation of cyclin A does not require its phosphorylation by CDC2 and cyclin-dependent kinase 2. J Biol Chem 2000;275:3158-67. (Pubitemid 30083014)
22. Chan YW, Ma HT, Wong W, Ho CC, On KF, Poon RYC. CDK1 inhibitors antagonize the immediate apoptosis triggered by spindle disruption but promote apoptosis following the subsequent rereplication and abnormal mitosis. Cell Cycle 2008;7:1449-61.
23. Ausubel F, Brent R, Kingston R, Moore D, Seidman J, Smith J, , et al. Current Protocols in Molecular Biology. New York: John Wiley & Sons; 1991
24. Poon RYC, Toyoshima H, Hunter T. Redistribution of the CDK inhibitor p27 between different cyclin. CDK complexes in the mouse fibroblast cell cycle and in cells arrested with lovastatin or ultraviolet irradiation. Mol Biol Cell 1995;6:1197-213.
25. Siu WY, Arooz T, Poon RYC. Differential responses of proliferating versus quiescent cells to adriamycin. Exp Cell Res 1999;250:131-41. (Pubitemid 29391577)
26. Chan YW, On KF, Chan WM, Wong W, Siu HO, Hau PM, et al. The kinetics of p53 activation versus cyclin E accumulation underlies the relationship between the spindle-assembly checkpoint and the post-mitotic checkpoint. J Biol Chem 2008;283:15716-23.
27. Siu WY, Lau A, Arooz T, Chow JP, Ho HT, Poon RYC. Topoisomerase poisons differentially activate DNA damage checkpoints through ataxia-telangiectasia mutated-dependent and -independent mechanisms. Mol Cancer Ther 2004;3:621-32. (Pubitemid 39193741)
28. Yam CH, Siu WY, Kaganovich D, Ruderman JV, Poon RYC. Cleavage of cyclin A at R70/R71 by the bacterial protease OmpT. Proc Natl Acad Sci U S A 2001;98:497-501. (Pubitemid 32105070)
29. Fung TK, Siu WY, Yam CH, Lau A, Poon RYC. Cyclin F is degraded during G2-M by mechanisms fundamentally different from other cyclins. J Biol Chem 2002;277:35140-9.
30. Ho CC, Siu WY, Lau A, Chan WM, Arooz T, Poon RYC. Stalled replication induces p53 accumulation through distinct mechanisms from DNA damage checkpoint pathways. Cancer Res 2006;66:2233-41.
31. Vassilev LT, Tovar C, Chen S, Knezevic D, Zhao X, Sun H, et al. Selective small-molecule inhibitor reveals critical mitotic functions of human CDK1. Proc Natl Acad Sci U S A 2006;103:10660-5. (Pubitemid 44078033)
32. Ng CP, Lee HC, Ho CW, Arooz T, Siu WY, Lau A, et al. Differential mode of regulation of the checkpoint kinases CHK1 and CHK2 by their regulatory domains. J Biol Chem 2004;279:8808-19. (Pubitemid 38295939)
33. Habu T, Kim SH, Weinstein J, Matsumoto T. Identification of a MAD2-binding protein, CMT2, and its role in mitosis. EMBO J 2002;21:6419-28.
34. Xia G, Luo X, Habu T, Rizo J, Matsumoto T, Yu H. Conformation-specific binding of p31(comet) antagonizes the function of Mad2 in the spindle checkpoint. EMBO J 2004;23:3133-43. (Pubitemid 39093607)
35. Vogel C, Kienitz A, Muller R, Bastians H. The mitotic spindle check-point is a critical determinant for topoisomerase-based chemotherapy. J Biol Chem 2005;280:4025-8. (Pubitemid 40288565)
36. Nitta M, Kobayashi O, Honda S, Hirota T, Kuninaka S, Marumoto T, et al. Spindle checkpoint function is required for mitotic catastrophe induced by DNA-damaging agents. Oncogene 2004;23:6548-58. (Pubitemid 39265518)
37. Heald R, McLoughlin M, McKeon F. Human wee1 maintains mitotic timing by protecting the nucleus from cytoplasmically activated Cdc2 kinase. Cell 1993;74:463-74. (Pubitemid 23244612)
38. Jin P, Hardy S, Morgan DO. Nuclear localization of cyclin B1 controls mitotic entry after DNA damage. J Cell Biol 1998;141:875-85. (Pubitemid 28243956)
39. Chan YW, Chen Y, Poon RYC. Generation of an indestructible cyclin B1 by caspase-6-dependent cleavage during mitotic catastrophe. Oncogene 2009;28:170-83.